Abstract:Background: Although tomoregulin-1 (TMEFF1) is involved in embryonic development and central nervous system regulation and is a cancer suppressor gene in brain cancers, its role in endometrial carcinoma remains unclear. Methods: The expression and prognostic value of TMEFF1 were analyzed by bioinformatics methods and immunohistochemistry. An endometrial carcinoma cell line with low expression of TMEFF1 was constructed. Scratch and Transwell assays were used to determine the effect of TMEFF1 on cell invasion and migration. Changes in key proteins in the MAPK and PI3K/AKT signaling pathways and in epithelial-mesenchymal transition (EMT)-related proteins were analyzed using western blot. Chromatin immunoprecipitation assay (ChIP) was performed to identify whether the TMEFF1 promoter region binds to the transcription factor p53. Results: TMEFF1 was significantly upregulated in endometrial carcinoma, was closely associated with FIGO stage (P=0.021) and lymph node metastasis (P=0.029), and was an independent risk factor for prognosis (P=0.044). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses showed that TMEFF1 and its related genes are involved in the cell cycle, regulation of mitosis, epigenetics, neural development, cell biological signal transduction and some key signal pathways. We also identified kinases, microRNAs and a transcription factor network related to TMEFF1 and the effect of TMEFF1 mutation on prognosis. In vitro knockdown of TMEFF1 significantly inhibited cell invasion and migration. Knockdown of TMEFF1 inhibited Epithelial-mesenchymal transition (EMT) and activation of the MAPK and PI3K/AKT pathways. However, the transcription factor p53 was not found to regulate the TMEFF1 gene. Conclusion: TMEFF1 plays an important role in endometrial carcinoma and may thus be a potential anticancer therapeutic target for endometrial carcinoma.

Overexpression of TMEM158 Contributes to Ovarian Carcinogenesis

Inhibition of TMEM45A Suppresses Proliferation, Induces Cell Cycle Arrest and Reduces Cell Invasion in Human Ovarian Cancer Cells.

Knockdown of TMEM45A gene suppresses proliferation, induces cell cycle arrest and reduces invasion ability of human ovarian cancer cells

Tumor-Suppressor Gene Transmembrane Protein 98 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer

Overexpression of TMEFF1 in Endometrial Carcinoma and the Mechanism Underlying its Promotion of Malignant Behavior in Cancer Cells

Upregulation and Biological Function of Transmembrane Protein 119 in Osteosarcoma

TMEM158, as plasma cfRNA marker, promotes proliferation and doxorubicin resistance in ovarian cancer

Overexpression and biological function of TMEM48 in non-small cell lung carcinoma

TMEM158 promotes pancreatic cancer aggressiveness by activation of TGF1 and PI3K/AKT signaling pathway

TMEM158 promotes pancreatic cancer aggressiveness by activation of TGFβ1 and PI3K/AKT signaling pathway

Inner nuclear membrane protein TMEM201 promotes breast cancer metastasis by positive regulating TGFβ signaling

TMTC1 promotes invasiveness of ovarian cancer cells through integrins β1 and β4

Loss of TMEM126A Promotes Extracellular Matrix Remodeling, Epithelial-to-mesenchymal Transition, and Breast Cancer Metastasis by Regulating Mitochondrial Retrograde Signaling

TMEM166 inhibits cell proliferation, migration and invasion in hepatocellular carcinoma via upregulating TP53

Decoding the Expressions, Immune Relevance, and Prognostic Values of Ferroptosis Gene TMEM189: A Pan-Cancer Analysis

TMEM45B, Up-Regulated in Human Lung Cancer, Enhances Tumorigenicity of Lung Cancer Cells

TMCO1 regulates cell proliferation, metastasis and EMT signaling through CALR, promoting ovarian cancer progression and cisplatin resistance

Downregulation of TMEM 176 A suppresses cell growth and proliferationin non-small cell lung cancer

Downregulation of TMEM220 Promotes Tumor Progression in Hepatocellular Carcinoma

Targeting TMEM88 as an Attractive Therapeutic Strategy in Malignant Tumors

Inhibition of TMEM16A expression suppresses growth and invasion in human colorectal cancer cells.